Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation.

Cytometry. Part B, Clinical cytometry - 1 Mar 2020

Behbehani Gregory K, Finck Rachel, Samusik Nikolay, Sridhar Kunju, Fantl Wendy J, Greenberg Peter L, Nolan Garry P

Abstract excerpt

BACKGROUND: We sought to enhance the cytometric analysis of myelodysplastic syndromes (MDS) by performing a pilot study of a single cell mass cytometry (MCM) assay to more comprehensively analyze patterns of surface marker expression in patients with MDS. METHODS: Twenty-three MDS and five healthy donor bone marrow samples were studied using a 34-parameter mass cytometry panel utilizing barcoding and internal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Needle
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Marrow Cells

Share to Flow Cytometry

Share to Immunophenotyping

Share to Myelodysplastic Syndromes

Share to Pilot Projects

Share to Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 31917512
DOI: 10.1002/cyto.b.21860
PMCID: PMC9292828

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation.PMID 31917512Read ↗

Profiling Myelodysplastic Syndromes by Mass Cytometry Demonstrates Abnormal Progenitor Cell Phenotype and DifferentiationSemantic proximity Read ↗

The Use of Flow Cytometry in Myelodysplastic Syndromes: A ReviewSemantic proximity Read ↗

Unraveling the molecular pathophysiology of myelodysplastic syndromes.Semantic proximity Read ↗

Epidemiology and Pathogenesis of Myelodysplastic Syndrome.Semantic proximity Read ↗

Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience.Semantic proximity Read ↗

Myelodysplastic neoplasms dissected into indolent, leukaemic and unfavourable subtypes by computational clustering of haematopoietic stem and progenitor cellsSemantic proximity Read ↗

The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes.Semantic proximity Read ↗

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionSemantic proximity Read ↗

[Diagnosis of MDS: morphology, chromosome abnormalities and genetic mutations].Semantic proximity Read ↗

Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.Semantic proximity Read ↗

Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.Semantic proximity Read ↗

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.